First, recent study reveals that nucleutide analogues, rather than nucleoside analogues, provide additional effect to induce expression of interferon-λ3 [29] which will induce IFN-stimulated genes and inhibit hepatitis B surface antigen (HBsAg) production in hepatoma cells. Here, IFNA1 is linked to hepatocellular carcinoma.